|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 35/00 | (2018.01) |
| A61K 31/7115 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 31/7115 | (2013.01) | ||
| A61K 39/39 | (2006.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K2039/55561 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| C07K 14/435 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61N 5/00 | (2006.01) | ||
| A61K 39/39 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K2039/54 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 35/04 | (2018.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3204040 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15848691.0 |
| Date of filing the European patent application | 2015-10-09 | |
| (97) | Date of publication of the European application | 2017-08-16 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/054899 |
| Date | 2015-10-09 |
| (87) | Number | WO 2016/057898 |
| Date | 2016-04-14 |
| (30) | Number | Date | Country code |
| 201462062274 P | 2014-10-10 | US | |
| 201562218934 P | 2015-09-15 | US |
| (72) |
WANG, Daqing , US
JIANG, Wayne , US
AGRAWAL, Sudhir , US
|
| (73) |
Idera Pharmaceuticals, Inc. ,
167 Sidney Street, Cambridge, MA 02319,
US
|
| (54) | TREATMENT OF CANCER USING TLR9 AGONISTS AND CHECKPOINT INHIBITORS |
| TREATMENT OF CANCER USING TLR9 AGONISTS AND CHECKPOINT INHIBITORS |